ARCHIVES

FDA Offers Grants For Conferences

This article is from The Cancer Letter archive.

Vol. 13 No. 18 | May 1, 1987

Download PDF Visit The Full Archive

Related Articles

New Jersey Commission Calls For Major Hike In Cancer Spending

September 25, 1987

NCI Cooperative Group Clinical Trials Approved

December 25, 2009

NCAB Gives Final Approval to New Guidelines for P01s

May 29, 1987

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH

June 24, 1988